Friday - March 27, 2026

Category Archives: Marketing & Sales

TECHSPO Silicon Valley 2026 Unites Business, Tech and Marketing Leaders for High-Impact Expo

San Francisco, CA – TECHSPO Silicon Valley Technology Expo returns June 16-17, 2026, to the Grand Hyatt San Francisco Hotel, uniting business leaders, technologists, marketers, and innovators for a high-impact, two-day showcase of next-generation digital technology. Part of the globally … Continue reading →

TECHSPO San Francisco 2026 Unites Business, Tech and Marketing Leaders for High-Impact Expo

San Francisco, CA – TECHSPO San Francisco Technology Expo returns June 16-17, 2026, to the Grand Hyatt San Francisco Hotel, uniting business leaders, technologists, marketers, and innovators for a high-impact, two-day showcase of next-generation digital technology. Part of the globally … Continue reading →

Osteoarthritis Clinical Trial Pipeline Advances as 100+ Companies Develop 110+ Novel Therapies Across All Clinical Stages, Finds DelveInsight | Biosplice Therapeutics, Regeneron Pharmaceuticals

Osteoarthritis – Pipeline Insight, 2026 The leading Osteoarthritis companies include Biosplice Therapeutics, Cynata Therapeutics, Bone Therapeutics S.A, Regeneron Pharmaceuticals, Techfields Pharma, Ampio Pharmaceuticals, Asahi Kasei Pharma, Taiwan Bio Therapeutics, OliPass Corporation, Bioventus, Medipost, LG Chem, ICM Biotech, UnicoCell Biomed, Magellan … Continue reading →

Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | CG Oncology, Janssen, Tyra Biosciences, UroGen Pharma

Non Muscle Invasive Bladder Cancer – Pipeline Insight, 2026 According to DelveInsight’s report, the leading Non Muscle Invasive Bladder Cancer companies include CG Oncology, Janssen Research & Development LLC, Tyra Biosciences Inc., UroGen Pharma Ltd., Prokarium Ltd., Protara Therapeutics, ImmVira … Continue reading →

DigiMarCon Northwest 2026 Returns to Vancouver, Bringing the Future of Digital Marketing to the Global Stage

Vancouver, BC – DigiMarCon Northwest, the premier digital marketing, media, advertising, and business conference and exhibition in the BC, will return April 20-21, 2026, at the Paradox Hotel Vancouver in Vancouver, BC. The three-day event will unite marketers, brands, agencies, … Continue reading →

Metastatic Triple Negative Breast Cancer Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Abbisko Therapeutics, Phoenix Molecular Designs

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Metastatic Triple Negative Breast Cancer pipeline constitutes 10+ key companies continuously working towards developing 12+ Metastatic Triple Negative Breast Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, … Continue reading →

Myasthenia Gravis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Alpine Immune Science, Toleranzia, Cabaletta, Rallybio, Alexion Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myasthenia Gravis pipeline constitutes 20+ key companies continuously working towards developing 22+ Myasthenia Gravis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →